| __timestamp | Alkermes plc | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 12402000000 |
| Thursday, January 1, 2015 | 4019000 | 17449000000 |
| Friday, January 1, 2016 | 2301000 | 17834000000 |
| Sunday, January 1, 2017 | 7232000 | 19551000000 |
| Monday, January 1, 2018 | 68895000 | 18265000000 |
| Tuesday, January 1, 2019 | 52816000 | 15607000000 |
| Wednesday, January 1, 2020 | 1946000 | 15410000000 |
| Friday, January 1, 2021 | 1020000 | 16541000000 |
| Saturday, January 1, 2022 | 393842000 | 17482000000 |
| Sunday, January 1, 2023 | 270806000 | 19381000000 |
| Monday, January 1, 2024 | 245326000 | 22873000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Dr. Reddy's Laboratories Limited has consistently outpaced Alkermes plc in R&D investment. From 2014 to 2023, Dr. Reddy's Laboratories increased its R&D spending by approximately 56%, reaching a peak in 2024. In contrast, Alkermes plc's R&D expenditure fluctuated significantly, with a notable spike in 2022, but overall, it remained a fraction of Dr. Reddy's investment.
This disparity highlights Dr. Reddy's strategic focus on innovation, potentially positioning it as a leader in developing new therapies. Meanwhile, Alkermes' variable spending suggests a more cautious approach, possibly reflecting different strategic priorities or financial constraints. As the pharmaceutical landscape continues to shift, these investment patterns may influence each company's competitive edge and market positioning.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
R&D Spending Showdown: Alkermes plc vs Viridian Therapeutics, Inc.
Research and Development Investment: Alkermes plc vs MiMedx Group, Inc.